Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Dopaminergic partial agonist with potential against both parkinson's disease and psychosis (DOPARTAGO)

Dal 2003-01-01 al 2004-12-31

Dettagli del progetto

Costo totale:

EUR 1 689 900

Contributo UE:

EUR 809 900

Coordinato in:

Netherlands

Meccanismo di finanziamento:

CRS - Cooperative research contracts

Coordinatore

AXON BIOCHEMICALS B.V.
Netherlands
Elsschotlaan 32
9721 WN GRONINGEN
Netherlands
See on map
Contatto amministrativo: Hakan WIKSTROEM

Partecipanti

ACADIA PHARMACEUTICAS A/S
Denmark
Fabriksparken, 58
2600 GLOSTRUP
Denmark
See on map
Contatto amministrativo: Bo-Ragnar TOLF
APOTEKET AB
Sweden
Prismavagen, 2
14175 KUNGENS KURVA
Sweden
See on map
Contatto amministrativo: Erling EHRIN
INDEPENDENT PHARMACEUTICA AB
Sweden
c/o Revisorspoolen Matsson and Co - Tegnergatan 37
11161 STOCKHOLM
Sweden
See on map
Contatto amministrativo: Torgny SVENSSON
NETHERLANDS RESEARCH SCHOOL FOR ASTRONOMY - LEGALLY REPRESENTED BY UNIVERSITY OF GRONINGEN
Netherlands
5,Broerstraat 5
9712 CP GRONINGEN
Netherlands
See on map
Contatto amministrativo: Andries P. BRUINS
NORDIC SYNTHESIS AB
Sweden
69 85 KARLSKOGA
Sweden
See on map
Contatto amministrativo: Soren OLSSON
SCANTOX
Denmark
Hestehavevej 36 A, Ejby
4623 LILLE SKENSVED
Denmark
See on map
Contatto amministrativo: C. Nicholas EDWARDS